A carregar...
Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
Among the pharmaceutical options available for treatment of ovarian cancer, increasing attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation prolongs the persistence of the drug in the circulation and potentiates intratumor accumulation. Pegylate...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Hindawi Publishing Corporation
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3612436/ https://ncbi.nlm.nih.gov/pubmed/23577259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/898146 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|